Highlights
NASDAQ: EGRX       Eagle Pharmaceutical
Last Price Today's Change   Day's Range   Trading Volume
53.37   -16.67 (23.80%)  50.52 - 71.88  1,855,704

Overview

 
Avg Volume (4 weeks):272,192
4 Weeks Range:50.52 - 83.80
4 Weeks Price Volatility (%):
8.56%
52 Weeks Range:42.33 - 97.15
52 Weeks Price Volatility (%):
20.14%
Average Price Target: 65.00
Price Target Upside/Downside: +11.63

Headlines



No recent Headlines for this stock.


Business Background

Eagle Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company focuses on developing and commercializing injectable products in the critical care and oncology areas. The Company's product portfolio includes products, including Argatroban; Ryanodex; docetaxel injection, non-alcohol formulation; and Bendeka. Its advanced candidates include EP-3101 (bendamustine Resistance Temperature Detectors (RTD)) (EP-3101), EP-4104 (dantrolene sodium for exertional heat stroke (EHS)) (EP-4104), EGL-4104-C-1702 (dantrolene sodium for drug induced hyperthermia), EP-5101 (pemetrexed) (EP-5101) and EGL-5385-C-1701 (fulvestrant). Its product portfolio focuses on oncology, critical care and orphan diseases. Bendamustine is an alkylating agent approved for use in chronic lymphocytic leukemia (CLL), and indolent B-cell non-Hodgkin's lymphoma (NHL), that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen.

  Be the first to like this.
 


 

3351  3825  595  654 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AMD 14.76+0.65 
 T 38.03+1.81 
 F 11.06-0.21 
 BAC 24.21-0.27 
 GDX 22.85+0.58 
 DCTH 0.136-0.011 
 AKS 6.24-0.54 
 XLF 25.05-0.17 
 X 26.20+1.76 
 EEM 44.01+0.36 
Partners & Brokers